TG and breast carcinoma: If this is indeed the case, then as an outgrowth of the discussions above, should primary care physicians monitor serum thyroid hormone levels in all women patients as a breast cancer risk factor and concentrate breast cancer screening efforts in patients with thyroid hormone levels in the upper one-half of the normal range?